课题基金 / 基金详情

Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India

Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
制定和测试印度预防心血管疾病的协作质量改进计划 (C-QIP)
批准号:
10677651
负责人:
Kavita Singh
金额:
$6.92万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-27 至 2025-04-30
关键词:
AdherenceAdministratorAdrenergic beta-AntagonistsAgeAmbulatory CareAngiotensin-Converting Enzyme InhibitorsAsiaAspirinAwardCardiovascular AgentsCardiovascular DiseasesCardiovascular systemCaringCase ManagerCause of DeathCessation of lifeCharacteristicsChronicChronic CareClinicClinicalClinical Decision Support SystemsClinical ResearchCollaborationsComplementComplexComputer softwareCountryDecision AidDevelopmentDisease OutcomeEconomicsEducational workshopEffectivenessEnrollmentEpidemicEuropeEuropeanEventFeedbackFogarty International CenterFoundationsFutureGoalsGovernmentGrantGrowthGuidelinesHealthHealth Care CostsHealth PersonnelHealth Services ResearchHealth systemHealthcareHealthcare SystemsHeart failureHeterogeneityIncomeIndiaIndividualInfrastructureInstitutionInternationalInterventionKnowledgeLearningLife StyleMeasuresMedical ResearchMentorsMissionModelingMorbidity - disease rateMyocardial InfarctionMyocardial IschemiaOnline SystemsOutcomeOutpatientsParticipantPatient CarePatientsPersonsPharmaceutical PreparationsPhysical activityPilot ProjectsPremature MortalityPreventionPrevention programPrivatizationProcessProcess MeasureProgram EvaluationProviderQuality of CareQuality of lifeRecurrenceReportingResearchResearch EthicsResearch PersonnelResearch TrainingResourcesRiskRuralSecondary PreventionSourceSouth AsianSoutheastern AsiaStandardizationStrokeTestingText MessagingTimeTrainingUnited KingdomUnited StatesUnited States National Institutes of HealthWorld Health Organizationacceptability and feasibilityadherence rateblood pressure reductionburden of illnesscardiovascular disorder epidemiologycardiovascular disorder preventioncardiovascular disorder therapycardiovascular healthcare costscare deliverycareercareer developmentchronic care modelcostdisabilityeffective interventionefficacy trialepidemiology studyevaluation/testingexperiencefeasibility testingglobal healthgood dietgroup interventionhealth care deliveryhealth organizationhealth related quality of lifehealthy lifestyleimplementation fidelityimplementation scienceimprovedimproved outcomeinnovationknowledge translationlifestyle interventionliteracylow and middle-income countriesmHealthmortalitymultidisciplinarynovelpragmatic interventionprocess improvementproductivity lossprogramsprospectivesmoking cessationsocialstress managementsystematic reviewteam-based caretreatment as usualtrial comparing

项目摘要

项目成果

Kavita Singh的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The proposed K43 application aims to develop, implement, and evaluate a Collaborative Quality ImProvement (C-QIP) intervention (non-physician health worker, text messages for healthy lifestyle and clinical decision-support system) effect on processes of care measures and clinical outcomes among individuals with existing CVD in India using United Kingdom Medical Research Council (MRC) framework for developing and evaluating complex interventions. A growing body of research suggests several factors at the level of the patient, provider, and health system may effectively lower the impact of CVD in India, such as literacy, increased time spent with patients, and integrated health care. Maximizing CVD treatment in India must involve a cascade of processes from appropriate prescribing to longer-term adherence as well as low(er)-cost health service delivery innovations such as non-physician health workers and interactive web-based or mHealth-based clinical decision-support system for providers and patients. Multifaceted quality improvement intervention (including but not limited to non-physician health worker/case managers, team-based care, SMS reminders, interactive decision-aids for patients and providers, audit-and feedback mechanisms) have been successful in high-income countries for improving care among individuals with existing CVD, but have not been extensively evaluated in India. These interventions could be sources of innovation in CVD prevention, treatment, and control through implementation science research. During the career development period of this award, I will take courses in research ethics, program evaluation, and health services research to complement my prior training. I will participate in training, or workshops organized by the World Health Organization SEARO (South-East Asia Regional Office), to learn about the development of evidence-informed clinical standards and guidelines adapted to local country settings and healthcare systems. My unique background and training will serve as a strong foundation for the present proposal and for future career development as an independent, innovative investigator and leader in global CVD research. In 10 years, I envision myself as an India-based clinical researcher in global CVD epidemiology and prevention, with a focus in South Asia. My current and future training, institution, and mentoring team provide me excellent platform to discover novel ideas about improving cardiovascular health and ultimately disseminate and deliver them globally, including in the US. The NIH K43 grant can provide me the mentored clinical research training and research opportunities to pursue my career goals. Relevance Development of local solutions to improving CVD care by Indian practitioners may provide innovative ideas that are relevant to and applicable in the US. As such, this proposal aims to improve the delivery of chronic care for patients with CVD in India and capture the innovative potential of global health, a thematic goal of the NIH and part of the strategic mission of the Fogarty International Centre.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12905-022-01881-0
发表时间: 2022-07-25
期刊: BMC WOMENS HEALTH
影响因子: 2.5
作者: [Isabirye, Alone, Elwange, Bob Charlestine, Singh, Kavita, De Allegri, Manuela]
通讯作者: De Allegri, Manuela
DOI: 10.1136/bmjopen-2021-056408
发表时间: 2022-07-07
期刊: BMJ OPEN
影响因子: 2.9
作者: [Mohan, Bishav, Singh, Bhupinder, Singh, Kavita, Naik, Nitish, Roy, Ambuj, Goyal, Abhishek, SIngh, Gurbhej, Aggarwal, Shivaansh, Saini, Aftabh, Tandon, Rohit, Chhabra, Shibba Takkar, Aslam, Naved, Wander, Gurpreet Singh, Prabhakaran, Dorairaj]
通讯作者: Prabhakaran, Dorairaj
DOI: 10.5334/gh.1128
发表时间: 2022
期刊: GLOBAL HEART
影响因子: 3.7
作者: [Prabhakaran, Dorairaj, Singh, Kavita, Kondal, Dimple, Raspail, Lana, Mohan, Bishav, Kato, Toru, Sarrafzadegan, Nizal, Talukder, Shamim hayder, Akter, Shahin, Amin, Mohammad Robed, Goma, Fastone, Gomez-Mesa, Juan, Ntusi, Ntobeko, Inofomoh, Francisca, Deora, Surender, Philippov, Evgenii, Svarovskaya, Alla, Konradi, Alexandra, Puentes, Aurelio, Ogah, Okechukwu S., Stanetic, Bojan, Issa, Aurora, Thienemann, Friedrich, Juzar, Dafsah, Zaidel, Ezequiel, Sheikh, Sana, Ojji, Dike, Lam, Carolyn S. P., Ge, Junbo, Banerjee, Amitava, Newby, L. Kristin, Ribeiro, Antonio Luiz P., Gidding, Samuel, Pinto, Fausto, Perel, Pablo, Sliwa, Karen]
通讯作者: Sliwa, Karen
Cardiovascular health metrics in low and middle-income countries: A scoping review.
低收入和中等收入国家的心血管健康指标:范围界定审查。
DOI: 10.1016/j.ypmed.2023.107534
发表时间: 2023
期刊: Preventive medicine
影响因子: 5.1
作者: [Garegnani,Luis, Franco,JuanVíctorAriel, EscobarLiquitay,CamilaMicaela, Brant,LuisaCamposCaldeira, Lim,HooiMin, deJesusJessen,NeusaPerina, Singh,Kavita, Ware,LisaJayne, Labarthe,Darwin, Perman,Gastón]
通讯作者: Perman,Gastón
20
    Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
    Developing and testing Collaborative Quality ImProvement initiative (C-QIP) for prevention of cardiovascular disease in India
    海外基金